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Disorders of carbohydrate metabolism associated with
diabetes have long been recognized to be paralleled by
some alteration in lipid metabolism.

A 1978 study by the

Kentucky Diabetes Commission revealed a higher rate of
diabetes in Eastern Kentucky--6.8 per cent of the population as opposed to a 2.2 per cent average nationally.
Diabetes and its complications in this area was responsible
for the majority of hospitalizations and 30 deaths per
100,000 people.

The prevalence of diabetes in Kentuckians

aged 17 and younger is 1.6 times higher, and 2.17 times
higher in Kentuckians aged- 17-45, than the national
average.

Lipoprotein and lipid studies of diabetics are

of great importance since heart and vascular disease represent the most serious complication in the life of the
diabetic.

A diabetic group consisting of 12 outpatients whose
age ranged from 13-19 years was involved in this study.
Fasting blood specimens for patients were drawn on at
least two different occasions.

All patients were on

insulin treatment and a regulated diabetic control diet.
A control group consisted of a normal non-diabetic population of comparable age.
Venous blood samples were collected after overnight
fasts, and assayed for glucose, total serum cholesterol,
HDL cholesterol, LDL cholesterol, and serum triglycerides,
and polyacrylarnide electrophoresis of lipoproteins.
Total serum cholesterol was assayed according to the
Liebermann-Buchard method.

HDL cholesterol was deter-

mined using heparin-manganese precipitation, and the
method previously described for total serum cholesterol.
Triglycerides were assayed by an enzymatic determination
of glycerol.

LDL cholesterol was calculated according to

the following formula:
C

VLDL
C

= TG/5
C

C

LDL
Where

= Serum C =

HDL - TG/5

concentration of cholesterol in the LDL,
VLDL, HDL, fractions or in serum expressed
in mg/100 ml

TG

= serum triglycerides expressed in mg/100 ml

Glucose was assayed by the enzymatic method of Trinder.
Lipoprotein electrophoresis was performed using a modified polyacrylamide gel technique.
Within the diabetic group 67 per cent were found to
be hyperlipidemic.

Hyperlipidemic juveniles were classi-

fied on the basis of total cholesterol, LDL-cholesterol,
and triglycerides as verified by polyacrylamide gel
electrophoresis.

These juveniles were classified as

types IV, IIa, IIb in order of frequency.

When diabetic

juveniles were compared with non-diabetic juveniles,
statistically significant elevations of total cholesterol,
LDL-cholesterol, and a decreased HDL-cholesterol were
observed.

An increase in triglyceride was also observed

in the diabetic population, but was not statistically
significant.

Statistical tests were based on the standard

pooled t test.
The diabetic group was subdivided into two groups
based on good or poor diabetic control.

The poor control

group consisted of patients in whom only sporadic control
was noted, however, all were outpatients at the time of
sampling, and none were ketotic.

The most common features in hyperlipidemic juvenile
diabetics were an increased total cholesterol, LDLcholesterol, and a decreased HDL-cholesterol.

Hyper-

triglyceridemia was resolved with good diabetic control,
which is well substantiated by other studies, which
directly related degree of control with triglyceride
levels.

Cholesterol levels, both total and lipoprotein

fractions, showed mean differences as compared to the
non-diabetic group, regardless of control.

The higher

mean values of total cholesterol and LDL-cholesterol, and
the decreased HDL-cholesterol in the diabetic cases
indicate a disturbed lipid metabolism in the diabetic
juvenile.
Major risk factors for the development of atherosclerosis seem to be prominent in diabetes mellitus,
since hypercholesterolemia, elevated LDL-cholesterol
fraction or a decrease1-in the HDL-cholesterol fraction
represent a greater risk than in the non-diabetic.

The

ratios of Total Cholesterol/HDL-Cholesterol, LDLCholesterol/HDL-Cholesterol, were 3.8 and 2.5 times
higher respectively, in the diabetic juvenile when compared to the non-diabetic juvenile.

These ratios have

been found to be indicators of cardiovascular risk in

previous studies.

These findings indicate an accelerated

risk for these individuals since there is an alteration
in lipoprotein metabolism, and possibly an alteration in
the metabolism of the arterial walls , at an early age in
the juvenile diabetic.
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INTRODUCTION
Disorders of carbohydrate metabolism associated with
diabetes mellitus have long been recognized to be parallelled by some alteration in lipid metabolism.17,21,22,23
Investigators have reported elevated serum concentration
of cholesterol and triglyceride in diabetes. 17 , 21 , 22 , 23
The identification of hypercholesterolemia and hypertriglyceridemia as two of a number of coronary risk factors, and the susceptibility of diabetics to atherosclerosis, have directed interest toward abnormalities of lipid
metabolism in diabetes. 23

Lipoprotein and lipid studies

of diabetics are of great importance since heart and vascular disease represent the most s~rious complication in
the life of the diabetic. 1 3,17,21,22,23
Coronary atherosclerosis is characterized by an accumulation of lipid, primarily cholesterol, in the arterial wall.

Evidence that this may be due, in part, to a

filtration into the arterial intima of low density (LDL)
lipoprotein cholesterol has been well documented.J,ll,lS,l 9
There is also evidence that the transport of cholesterol
from the peripheral tissues to the liver for catabolism
and excretion may be a function of plasma high-density
lipoprotein (HDL), which also inhibits the uptake of LDL
by the peripheral tissues. 3 , 4 , 11 , 15 , 19

This would account

2

for an inverse relationship between HDL and the cardiovascular risk.

The amount of plasma HDL has been found

to be decreased in diabetes, 15 and elevated levels of
cholesterol and triglycerides have been reported in 25 to
50 per cent of diabetics. 13 , 22 ,2 3
A biochemical pathway to show how human cells gain
access to the cholesterol esters bound to LDL has been
proposed by Goldstein and Brown. 11

The sequential steps

involved in this pathway are as follows:

(1) Cells re-

quiring cholesterol synthesize a receptor that becomes
localized on the cell surface.
ceptor with high affinity.

(2) LDL binds to this re-

(3) The bound LDL is then

taken up by the cell via an endocytotic process.

(4) The

membrane receptor-LDL complex invaginates into the cell,
forming an endocytic vesicle which migrates through the
cytoplasm and fuses with a lysosome.

(5) The protein of

the LDL is hydrolyzed by lysosomal proteases to amino
acids.

(6) The cholesterol esters are hydrolyzed by a

lysosomal acid lipase.

(7) The free cholesterol produced

passively crosses the lysosomal membrane, and gains access
to the cellular compartment.1 1
The cell suppresses its own cholesterol synthesis,
having obtained cholesterol from LDL, by reducing the
activity of a rate controlling microsomal enzyme,
3-hydroxy-3-methyl glutaryl coenzyme A reductase (HMG CoA

3

reductase).

When excess cholesterol enters the cell

through the LDL pathway, it is stored in the cell in the
form of cholesterol ester droplets.

The formation of

cholesterol esters is triggered by the activation of acyl
CoA:

cholesterol acyl transfera~1e (ACAT) , a microsomal

enzyme that attaches a long fatty acid to free cholesterol.11
It has been postulated that HDL works in an opposing
manner.

Studies of the metabolism of arterial smooth

muscle cells show that HDL binds to the surface receptor
of smooth muscle cells as effectively as LDL, but HDL is
degraded much more slowly.

When cells were incubated with

an equal or higher concentration of HDL, no net increment
of cholesterol was noted.

The presence of HDL in the

medium inhibits uptake and degradation of LDL.4
A second mechanism is proposed whereby HDL serves to
clear cholesterol from the arterial wall.

As the mert'branes

of arterial cells exhibit biological turn over, and as
cells die and are renewed, cholesterol is released from
the tissues.

This cholesterol binds to HDL, where it is

converted to cholesterol esters by the enzyme lecithincholesterol acyl transferase (LCAT) . 11

This form of cho-

lesterol is then returned to the liver for excretion.
It has become increasingly apparent that the process
of atherosclerosis has a long natural history beginning

4

in early childhood. 2

The fact that hyperlipoproteinemia

is present in a large percentage of middle-aged diabetics
suggests that an alteration in carbohydrate metabolism of
juvenile diabetics may also produce an observable change
in lipid metabolism at an early age.

This metabolic

alteration may enhance the atherogenic process in these
juveniles.

The study of lipid profiles in these juve-

niles also affords a study of the atherogenic process,
uncomplicated by other chronic disease processes frequently seen in older diabetics.
The purpose of this study was to compare triglyceride, total cholesterol, HDL cholesterol and LDL cholesterol levels in the serum of diabetic and non-diabetic
adolescents of Eastern Kentucky.

The study was also de-

signed to analyze data for the identification of factors
of potential risk in the pathogenesis of atherosclerosis.
A conclusion that increased risk of atherosclerosis could
exist, would indicate that in the juvenile diabetic,
lipid metabolism, as well as carbohydrate metabolism,
should be monitored and controlled.
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MATERIALS AND VJETHODS
A diabetic group consisting of 12 outpatients whose
age ranged from 13-19 years was involved in this study.
Blood specimens from fasting patients were obtained on at
least two different occasions.

All patients were being

treated with insulin and a regulated diabetic diet.

A

control group consisted of a normal non-diabetic population of comparable age.
Venous blood samples were collected after overnight
fasts, and assayed photometrically for glucose, total
serum cholesterol, HDL cholesterol, LDL cholesterol and
serum triglyceride.

HDL and LDL levels were qualitated

by polyacrylamide electrophoresis of lipoproteins.
Blood Glucose
Glucose was assayed by the method developed by
Trinder. 24

Glucose is oxidized by glucose oxidase to

gluconic acid and hydrogen peroxide.

The hydrogen per-

oxide reacts in the presence of peroxidase, with phenol
and 4-amino phenazone to form a 0-quinone imine dye which
is measured photometrically.
Procedure
1.

Label tubes blank, standard, control, and sample.

6

2.

Pipet 4.0 ml of glucose reagent (BoehringerMannheim cat. no. 189197) into all cuvettes
(13

3.

X

100 mm) •

Add 0.02 ml of sample, standard, control and
distilled water to the respective cuvettes.
Mix all tubes well and incubate at 37°C for 10

4.

minutes.
5.

Read absorbance of standard, control and sample
at 540 mm.

6.

Calculate concentration of glucose as follows:
mg glucose/100 ml=
Absorbance of unknown x concentration of std.
Absorbance of standard
Total Serum Cholesterol

The Liebermann-Buchard method, as modified by Huang,
was used for cholesterol assays.

Cholesterol reacts

strongly with sulfuric acid to produce green colored bischolestadienyl-monosulfonic acids. 12
Procedure
1.

Label tubes, standard, control, sample and reagent
blank.

2.

Pipet exactly 3.0 ml of cholesterol reagent
(Stanbio Laboratory Co., Dallas, Tex.) into test
tubes.
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3.

Add 0.1 ml of cholesterol standard, control,
sample and distilled water into the appropriate
test tube.

4.

Mix all tubes well and incubate at room temperature for 20 minutes.

5.

Read absorbance of standard, control and sample
at 610 nm.

6.

Calculate cholesterol concentration by the following formula:
mg cholesterol/100 ml=
Absorbance of unknown x Concentration of std.
Absorbance of standard
HDL Cholesterol

HDL cholesterol was determined using the LiebermannBuchard method as described for total serum cholesterol,
in conjunction with heparin-manganese precipitation to
eliminate the VLDL and LDL fractions.
Procedure
1.

Label tubes control and sample.

2.

Pipet 1.0 ml of serum and controls into test
tubes, and add 0.1 ml of precipitating reagent
(Stanbio Laboratory, Dallas, Tex.).

3.

Mix all tubes well, centrifuge at 3,500 rpm for
approximately 10 minutes, then decant.
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4.

Add 0.2 ml of the supernatant to 3.0 ml of
cholesterol reagent (Stanbio Laboratory Co.,
Dallas, Tex.).

5.

Mix all tubes well and incubate at room temperature for 20 minutes.

6.

Read the absorbance of the solution at 610 nm.

7.

Calculate the HDL cholesterol concentration by
the following formula:
mg

HDL cholesterol/100 ml=

Absorbance of unknown
Absorbance of standard

x concentration of x•5 standard
Triglyceride
Triglyceride content was determined using an enzymatic method.

Triglycerides are saponified in the presence

of alcoholic potassium hydroxide to fatty acids and free
glycerol.

Glycerol then undergoes a series of coupled re-

actions, and the amount of NADH oxidized during the reaction is then measured.

The amount of NADH oxidized is pro-

portional to the amount of glycerol in the specimen.
Procedure
1.

Label tubes control and sample.

2.

Pipet into a test tube 0.2 ml of sample or control and 0.5 ml alcoholic potassium hydroxide.
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3,

Mix all tubes well, seal and incubate for 20-30
minutes at between 55~70°C.

4.

Allow tubes to cool to room temperature, then add
1.0 ml of 0.15 M magnesium sulfate.
and centrifuge.

5,

Mix tubes

Decant supernatant.

Add 0,5 ml of the supernatant to 2.5 ml of triglyceride reagent (Boehringer-Mannheim, cat. no.
125032) •

6.

Mix all tubes and incubate at room temperature for
5 minutes.

7.

Measure initial absorbance (A1), at 340 or 366 nm.

8.

Add 0.2 ml of glycerokinase to all tubes and mix.
Let all tubes stand for approximately 10 minutes,

9.

then read final absorbance (A 2 ); A= A1 - A2 •
Calculate triglyceride concentration according to
the following formula:
Va X MW X 8,5
a x D x Vs x 10

AX

A

= mg triglyceride/100 ml

= Difference in absorbance between initial
and final readings.

Va= Total assay volume= 3.04 ml
MW= Average molecular wei~ht of triglycerides
in human serum= 885.
a

= Absorbency coefficient·=3,30 cm 2/µ mole
at 366 nm.

10
D

= Light path= 1 cm

Vs

= Volume of the supernatant= 0.50 ml

10

= Conversion to mg/100 ml

8.5 = Dilution factor due to saponification and
neutralization of specimen
mg triglycerides/100 ml= 1386 x A
LDL Cholesterol
LDL cholesterol was calculated according to the following formula:
CVLDL = TG/5
CLDL

= Cserum ~ CHDL - TG/5

where
C = Concentration of cholesterol in the LDL,
VLDL, HDL fractions or in serum expressed
in mg/100 ml
TG=serum triglycerides expressed in mg/100 ml
Polyacrylamide Gel Electrophoresis
Polyacrylamide gel electrophoresis is a technique in
which separation is dependent upon electrophoretic mobility
and molecular size.6,l0, 15

This type of disc electro-

phoresis sharply delineates lipoprotein bands, and is the
more rapid of the electrophoretic methods used for separating lipoproteins.

The sample is prestained with Sudan

11
Black Bin a sample gel.

It is then resolved by electro-

phoresis in a discontinuous pH system consisting of a sample
gel, concentrating gel and separating gel.
Reagents
Solution A.

Dissolve 36.6 g of Tris ("Trizma base,"

Sigma Chemical Co., St. Louis, Mo.) and 0.23 ml of "TEMED"
(Eastman Organic Chemicals, Rochester, N.Y. cat. no. 8178)
in approximately 100 ml of distilled water.

Add 48 ml of

lNHCL and dilute to 200 ml with distilled water.
should be 8.9.

The pH

It is stable for three months at 4°C in a

brown bottle.
Solution B.

Dissolve 5.98 g of Tris (Trizma base) and

0.46 ml of TEMED in 25 ml of distilled water.

Add .48 ml

of lNHCL and dilute to 100 ml with distilled water.
pH should be 6.7.

The

It is stable for three months at 4°C

in a brown bottle.
Solution

c.

Dissolve 15.0 g of acrylamide (Eastman,

cat. no. 5521) and 0.40 g of bisacrylamide (Eastman, cat.
no. 8383) in 75 ml of distilled water, and dilute to 100 ml
with distilled water.

It is stable for three months at

4°C in a brown bottle.
Solution D.

Dissolve 20.0 g of acrylamide and 5.0 g

of bisacrylamide in water and dilute to 200 ml with
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distilled water.

It is stable for three months at 4°C

in a brown bottle.
Solution E.

Dissolve 8.0 mg of riboflavin (Sigma

Chemical Co., St. Louis, Mo.) in 100 ml of distilled water.
It is stable for three months at 4°C in a brown bottle.
Solution F.

Dissolve 200 g of sucrose in 400 ml of

water and dilute to 500 ml with distilled water.
Solution G.

Dissolve 0.14 g of ammonium persulfate in

50 ml of distilled water in a 100 ml volumetric flask, and
dilute to volume with distilled water.

It is stable for

one week at 4°C in a brown bottle.
Dye Solution.

Add 250 mg of Sudan Black B to 30 ml

of absolute ethanol, mix well, and dilute to 100 ml with
distilled water.

It is stable for one month at room tem-

perature in a brown bottle.
Separating Gel Solution.

Remove the desired amount of

solutions A, C, and G from their refrigerated bottles,
place suitable amounts in containers, and bring to room
temperature before combining them.

Combine solutions A,

C, and Gin the ratio of 1:1:2, by volume.

Prepare ap-

proximately 1.0 ml of the separating gel solution per
separating gel required.

The separating gel solution

should be prepared just before use.
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Concentrating Gel Solution.

Mix solutions B, D, E,

and Fin the ratio of 1:2:1:4, by volume.

It is stable

for one month at 4°C in a brown bottle.
Sample Gel Solution.

Just before use, add 8 parts of

concentrating gel solution to 1 part of dye solution and
mix by gentle inversion.
Reservoir Buffer.
Coleman

&

Dissolve 6.0 g of Tris (Matherson,

Bell, no. 7060) and 28.8 g of glycine (Sigma)

in about 850 ml of distilled water.

If necessary, adjust

the pH to 9.5 with Tris or glycine.

Dilute to 1 liter

with distilled water.

The reservoir buffer may be used

for 7 days (based on two runs per day).
Equipment
The Buchler Polyanalyst gel system and power supply
were used for electrophoretic separations (Buchler-Cotlove
Instruments).

The Gelman densitometer· (Model DCO-16) was

used to evaluate band migration (Gelman Instrument Co.,
Ann Arbor, Mich.).
PYocedure
1.

Add 1.0 ml of freshly prepared separating gel
solution to each gel tube.

Carefully add water

on top of the gel solution to prevent a curved
meniscus from forming as the gel polymerizes.
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The separating gel polymerizes, if undisturbed, in
30 minutes at room temperature.

(All polymeriza-

tion procedures must be performed under intense
light.)
2.

After photopolymerization is complete, invert the
tubes and blot on absorbent paper.

3.

Add 0.05 ml of concentrating gel solution.

Layer

the gel solution as above, and allow tubes to
remain undisturbed for 10 minutes.
4.

After polymerization is complete, invert the tubes
and blot on absorbent paper.

5.

Add 0.02 ml of serum and 0.1 ml of sample gel
solution to each tube.

Mix each tube by inversion

and layer each tube with reservoir buffer.

Allow

the tubes to remain undisturbed for 20-30 minutes.
6.

Insert the tubes into the electrophoretic cell.
Electrophoresis should be run for 25-30 minutes at
5 rnillamperes per gel tube.

7.

Densitrometric scans are made following electrophoresis using a 615 nm interference filter.
is no need to remove the gel from the tube.

There
If

densitometry cannot be immediately performed,
the tubes should be refrigerated and shielded to
avoid color fading.
8.

Chylomicrons remain in the sample gel.

VLDL are

15

retained near the origin of the separation gel.
LDL migrates about half the distance of the separating gel, and HDL is the fastest migrating
anodic fraction, migrating to near the end of
the tube.
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RESULTS AND DISCUSSION
Within the diabetic group 67 per cent were found
to be hyperlipidemic.

Hyperlipidemic juveniles were

classified, on the basis of total cholesterol, LDLcholesterol and triglycerides, as lipoprotein phenotypes IV, IIa, IIb, in order of decreasing frequency.·B
These results were then verified, qualitatively, by
densitometric analysis of the polyacrylamide gels.
When diabetic juveniles were compared with non-diabetic
juveniles, statistically significant elevations of
total cholesterol, LDL-cholesterol, and a decreased
HDL-cholesterol were observed (Table I).

An increase

in triglyceride was also observed in the diabetic
population, but was not statistically significant.
Statistical tests were based on the standard pooled
t test.
The diabetic group was subdivided into two groups
based on good or poor diabetic control.

The poor con-

trol group consisted of patients in whom only sporadic
control was noted, however, all were outpatients at the
time of sampling, and none were ketotic.

Juvenile

diabetics in good control were found to have significantly lower triglyceride levels when compared to
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diabetics with poor control (Table II).

There were no

statistically significant differences in HDL-cholesterol,
total cholesterol, and LDL-cholesterol.

Although the

cholesterol and LDL-cholesterol were higher, HDLcholesterol was lower in the poor control-group.
Table I
Diabetic Juveniles vs. Non-'Diabetic Juveniles
Non-Diabetic Group

Diabetic Group

Glucose
(mg/100 ml) + S.D.

90 + 14.3
----

Triglyceride
(mg/100 ml)± S.D.

132 + 34.B

145 +

68. l

Total Cholesterol
(mg/100 ml)± S.D.

161 + 26.4
---

224 +

-

44.l

254 + 124.3
--

HDL-Cholesterol
(mg/100 ml) ± S.D.

46 +

8.1

33 +

9.4

LDL-Cholesterol
(mg/100 ml) + S.D.

91 + 20.3
- --

-162 -+

42.5

Statistical tests are based on standard pooled t test
(p < 0.05), where n = 12 for non-diabetic group and
n = 12 for diabetic group. Significant deviations are
underscored.
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Table II
Good Control Diabetic Juveniles vs. Poor
Control Diabetic Juveniles
Good Control

Poor Control

Glucose
(mg/100 ml) + S .D.

129 + 14.5

Triglyceride
(mg/100 ml) + S.D.

87 + 21.5

186 + 58.3

Total Cholesterol
(mg/100 ml) + S.D.

205 + 37.8

238 + 46.3

-

HDL-Cholesterol
(mg/100 ml) + S.D.
LDL-Cholesterol
(mg/100 ml) + S.D.

-

31 +

342 + 78
--

6.5

144 + 44.6

34 +

6.8

166 + 44.9

Statistical tests are based on standard pooled t test
(p < 0.05) where n = 5 for good control diabetics and
n = 7 for poor control diabetics. Significant deviations are underscored.

Statistical comparison of good control diabetics
with the non-diabetic population illustrated that while
control does lower the triglyceride levels, triglyceride
levels were statistically significantly lower in the
diabetic group than in the non-diabetic group.
both were within normally used clinical limits.

However,
This is
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in agreement with the lipid study by Wille.22

LDL-

cholesterol levels were still significantly higher, and
HDL-cholesterol levels were significantly lower for
juveniles of the same age (Table III).
Table III
Good Control Juvenile Diabetics vs. NonDiabetic Juvenile Group
Good Control
Diabetics

Non-Diabetic
Control

Glucose
(mg/100 ml) + S.D.

129 + 14.5

90 + 14.3

Triglyceride
(mg/100 ml)~ S.D.

87 + 21.5

132 + 34.8

Total Cholesterol
(mg/100 ml)~ S.D.

205 + 37.8

161 + 26.4

HDL-Cholesterol
(mg/100 ml) + S.D.
LDL-Cholesterol
(mg/100 ml) + S.D.

-

31 +

6.5

144 + 44.6

---

---

46 +

8.1

91 + 20. 3

Statistical tests are based on standard pooled t test
(p < 0.05) where n = 5 for good control diabetics, and
n = 12 for non-diabetic control. Significant deviations
are underscored.
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When poorly controlled diabetics were compared with
the non-diabetic controls, total cholesterol, triglyceride and LDL-cholesterol levels were also significantly
different (Table IV).

HDL-cholesterol levels were again

observed to be significantly decreased.
Table IV
Poor Control Diabetic Juveniles vs. NonDiabetic Control Juveniles
Poor Con"(::rol
Diabetics

Non-Diabetic
Controls

Glucose
(mg/100 ml)~ S.D.

342 + 78

Triglyceride
(mg/100 ml) ~ S.D.

186 + 58.3

132 + 34.8

Total Cholesterol
(mg/100 ml)~ S.D.

238 +
---

46.3

161 + 26.4

HDL-Cholesterol
(mg/100 ml) ~ S.D.

34 +

6.8

LDL-Cholesterol
(mg/100 ml) + S.D.

-

166 + 44.9

---

90 + 14.3

46 +

8.1

91'+ 20.3

Statistical tests are based on standard pooled t test
(p < 0.05) where n = 7 for poor control diabetics, and
n = 12 for non-diabetic controls. Significant deviations are underscored.
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Age, sex, age at onset and duration of disease were
found to be non-significant factors in hyperlipidemic
patients.

All patients used in this study were not hyper-

tensive, and the diabetic patients were treated with
insulin and a regulated diet alone at the time of sampling.
The most common features in hyperlipidemic juvenile
diabetics were an increased total cholesterol and LDLcholesterol levels, and a decreased HDL-cholesterol.
Hypertriglyceridemia was resolved with good diabetic control.

This observation is in agreement with other

studies which also directly related degree of diabetic
control with triglyceride levels. 1 , 5 , 13 ,l4, 22 , 2 3
Cholesterol levels, both total and lipoprotein fractions,
showed mean differences when compared to the non-diabetic
group, regardless of control.

The higher mean values of

total cholesterol and LDL-cholesterol, and the decreased
HDL-cholesterol in the diabetic cases indicate a disturbance of the normal lipid metabolism in the diabetic
juvenile.
Major risk factors for the development of atherosclerosis seem to be prominent in diabetes mellitus, since
hypercholesterolemia, elevated LDL-cholesterol fraction
or a decrease in the HDL-cholesterol fraction represent a
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greater risk than in the non-diabetic.21

The ratios of

total cholesterol/HDL-cholesterol and LDL-cholesterol/
HDL-cholesterol were 2.0 and 2.5 times higher respectively
in the diabetic juvenile than in the non-diabetic
juvenile. •· These ratios have been found to be indicators
of cardiovascular risk in previous studies.B

These

results suggest an accelerated risk for diabetic juveniles since there is an alteration in lipoprotein metabolism, and probably an alteration of the'm~tabolism in'
the arterial walls, which is initiated at an early age in
·the juvenile diabetic.19
Therefore, in the juvenile diabetic, even those
diabetics exhibiting controlled blood glucose, there are
prominent lipid and lipoprotein levels that elevate the
risk of cardiovascular disease.

The total cholesterol,

LDL-cholesterol, HDL-cholesterol and triglyceride levels
should be monitored, even in the diabetic with controlled
blood glucose levels.
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